Research Article
Serum and Vitreous Concentrations of Omentin-1 in Diabetic Retinopathy
Table 2
Serum and vitreous omentin-1 levels in controls, diabetic patients without DR, NPDR patients, and PDR patients.
| | Omentin-1 (ng/mL) | Controls () | Without DR () | NPDR () | PDR () | value |
| | Serum | 208.31 (164.20–251.20) | 184.41 (142.50–206.14) | 166.97 (132.96–199.21) | 139.96 (119.28–157.87) | <0.001 | | Vitreous | 96.00 (75.24–112.64) | 81.46 (67.84–96.39) | 64.28 (53.08–74.45) | 50.36 (39.91–57.73) | <0.001 | | Serum/vitreous ratio | 1.99 (1.72–2.63) | 2.17 (1.82–2.57) | 2.72 (2.08–3.37) | 2.88 (2.31–3.48) | <0.001 |
|
|
versus control; versus diabetic patients without DR; versus NPDR patients.
|
